The receptor is assigned the functional role of an alternative pathway of T-cell activation.*
(CD2) and ligand structures on sheep (T11TS) and human cells (LFA3) responsible for E rosette formation have been identified and
The receptor is assigned the functional role of an alternative pathway of T-cell activation.*
In several diseases of malignant or nonmalignant origin, diminished E rosette formation has been described. In some cases this inhibition has been ascribed to soluble serum factors.'-13 In Hodgkin's disease patients, E rosette-inhibiting factors were observed by Fuks et aI,l4 Ezdinli et al, I5 Holm et a1,I6 Bieber et al,I7 and Sinclair et a1.I8 Detailed characterization has not been carried out so far.
Hodgkin cell lines, established in long-term culture, have yielded important information about the biology of Hodgkin's disease. The characterization of the cell lines established in our laboratory (Schaadt 1980 , Diehl 1981 )L9,20 demonstrates that these cells interact with normal tissue by the release of biologic mediat~rs.~l-*~ One of these factors interferes with the E rosetting of peripheral T lymphocytes with sheep erythrocytes, which is mediated by the CD2 and T11TS antigen on the cell surface of the respective cells. Here we report on the purification and partial characterization of this rosette-inhibiting factor (RIF) spontaneously produced by Hodgkin-derived cell lines.
MATERIALS AND METHODS

Cell Lines
Hodgkin-derived cell lines. L428, L428KS, L428KSA, L540, and L591 represent in vitro counterparts of in vivo Hodgkin-and Sternberg-Reed cells. Characterization, establishment, and maintenance are published in detail else~here.'~.*~ L735 was established in our laboratory from a patient with T-cell acute lymphocytic leukemia (T-ALL). The cell line binds the monoclonal antibodies (MoAbs) CD3 (95%), CD4 (55%), CD8 (95%). and CD2 (95%). Cells are maintained in RPMI 1640 supplemented with 20% fetal calf serum (FCS) at a density of 0.5 to 1 x107 cells/mL. Doubling time is 60 hours. L735 was used for rosetting experiments to minimize interassay variability due to different donor peripheral blood lymphocytes (PBL). Of all T-cell lines tested (Molt, CEM, Jurkat), L735 showed highest rosetting capacity. Results obtained in the L735 assay were routinely compared with the conventional rosette assay.
L735. trols). The diminished E rosetting of T lymphocytes from
Hodgkin's patients was not further suppressed by added RIF. This factor inhibited binding of SRBC to their target cells at 37°C but not at 4°C. The factor could be stored lyophilized at -20°C and was stable at 56°C (30 minutes). RIF was inactive below pH 6 and above pH 9 or after trypsin digestion. Purification by affinity, ion exchange, and molecular sieve chromatography showed activity peaks at 12.5 Kd, 25 Kd, 50 Kd, and 100 Kd. 0 1990 by The American Society of Hematology.
Preparation of Supernatant
Culture supernatants of L428 cells ( 5 x IO6 cells/mL) grown for 3 days in FCS-free conditions were harvested and centrifuged once at 200g for 15 minutes, twice at 1.700g for 20 minutes. After addition of the protease inhibitor Aprotinin (IO00 U/mL; Trasylol, Bayer, Leverkusen, FRG) and adjustment of the pH with HEPES buffer (10 mmol/L final concentration, Whittaker Bioproducts, Walkersville, MD), the solution was passed through a 0.2-~m filter (Sartorius, Giittingen, FRG) and concentrated at 4OC by ultrafiltration (mol wt exclusion 5 Kd; Amicon, Danvers, MA). Unless specified otherwise, the material was then lyophilized.
Ion exchange chromatography. Lyophilized protein tested positive for activity was diluted in 10 mL of starting buffer (2 mg protein/mL 0.01 mol/L Tris-HC1, pH 8.0) and separated on a Mono Q anion exchange column/FPLC (1 mL; Pharmacia, Uppsala, Sweden) with a linear NaCl gradient (NaCI 1 mol/L; retention volume, 60 mL; flow rate, 1 mL/min).
Molecular sieve chromatography. Lyophilized supernatant was dissolved in 4 mL starting buffer for separation on a Bio-Gel A 0.5 column (120 x 2.6 cm, BioRad), 120 mg protein/mL 0.1 mol/L phosphate buffer, pH 7.2, flow rate 17.5 mL/min), and on a LKB TDK 4000 Blue Column/HPLC (Bromma, Sweden), 30 mg protein/mL 2 mol/L phosphate buffer, pH 7.2, flow rate 0.5 mL/min.
Chromatofocusing. Partially purified supernatant was applied to a Mono P column/FPLC (Pharmacia) with PBE (poly buffer exchanger) adjusted to pH 10.0 to 5.0 at a flow rate of 0.4 mL/min.
Determination of Protein Content
(BioRad KitII, BioRad, Richmond, CA).
Protein content was measured by a commercial protein assay
Protein-Gelelektrophoresis
PAGE) has been performed with the Phastsystem (Pharmacia).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
Amino Acid Analysis
Amino acid analysis has been performed with an analyzer from Applied Biosystems 420A by G. Multhaup at Professor K. Beyreuther's laboratory, ZMBH, Heidelberg, FRG.
Fluorescence-Activated Cell Scanner Analysis (FACSscan)
Fluorescence-activated cell Scanner (FACS) studies have been performed with a FACScan (Becton Dickinson, Mountain View, CA). Tl1,lA (10C7E9) and Tl1,lB (539/8a) were a kind gift of Professor S. Meuer (DKFZ, Heidelberg, FRG). T11,lB (OKTl 1) has been purchased from Ortho-mune (Raritan, NJ).
Magnetic Cell Sorter (MACS)
Lymphocyte subpopulations (T4+ and T8+) were separated by means of magnetic bead-coupled antibodies" using a sorting column from Biotechnische Gerate/Spezialelektronik (Bergisch Gladbach, FRG). Antibodies against CD4 (Biotin-IOT4) and CD8 (Biotin-IOT8) were purchased from Immunotech Laboratories (Marseille, France), magnetic biotin beads from S. Miltenyi (Biotechnische Gerate/Spezialelektronik, Bergisch-Gladbach, FRG).
Statistical Evaluation
The paired Students t test has been used to calculate the statistical significance of the given data. A deviation of more than 30% from the control values has proved to be a reliable criterium for practical purposes.
RESULTS
RIF Production by Different Cell Lines
Cell-free supernatants of the Hodgkin cell lines L428, L428KS, L428KSA, L540, and L591 grown under serumfree conditions were harvested at day 3 and tested for RIF activity. The supernatant of L428 provided highest activity compared to other Hodgkin cell lines (L428KS, L428KSA, L540, L591). For that reason L428 supernatants were chosen for factor purification. Serum-free supernatant of L428 was tested for the presence of RIF activity at days 1 through 6. Maximal inhibition was obtained at day 3, correlating with the overall viability of the cells in culture.
Determination of RIF Activity
Whereas the native supernatant of L428 inhibited E rosette formation, the same material did not show activity after concentration by Amicon filtration and lyophilization. When the concentrated material was rediluted to starting volume, activity was again demonstrable. In some serum-free supernatants from L428 cultivated from frozen stocks, E rosette inhibition could only be detected after dilution of supernatant. A possible explanation for these observations could be varying factor production. Comparison of our Hodgkin cell lines showed not only highest activity in fresh L428 supernatant but also highest dilutability. The effect of serial dilution of RIF activity is shown in Fig 1. At high-or low-factor concentration, no effect on E rosetting could be detected, whereas in between, significant inhibition was observed. This bell-shaped relationship and the degree of maximal rosette inhibition did not change during further purification, but the activity was found at higher dilutions while total protein content was decreasing. For all the data presented in this report, serial dilutions of RIF have been tested.
Physical Stability of RIP
The half-life of the RIF activity in crude supernatant or partially purified material in solution at 4OC or -2OoC was about 3 weeks. Storage at temperatures of 2OoC or 37OC caused a total loss of activity within hours. RIF was stable over months if stored at -8OOC or as a lyophilized preparation at -2OOC. Activity was preserved up to 30 minutes at 56OC but was completely lost after 1 minute at 100OC. RIF was inactivated under mild acidic (pH 6) or alkaline (pH 8) conditions (Table 1) . For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 
Enzyme Treatment
RIF activity of partially purified supernatant (after ion exchange chromatography) was retained when treated with neuraminidase but did not withstand trypsin incubation.
Chromatographic Purification
Chromatography (Fig 2) of the lyophilized supernatant (starting with 10 L resuspended in 4 mL) on a calibrated Biogel A 0.5 column yielded active fractions at 100, 50, and 12.5 Kd (Fig 3) . In a former purification, additional activity could be demonstrated at 25 Kd that could not be detected in the profile shown in Fig 3 due to overload of the column in the 50-Kd range.
Further purification of lyophilized active fractions was performed either on a hydroxylapatite column (elution of active RIF at 0.2 mol/L and between 0.4 and 0.6 mol/L phosphate concentration) or anion exchange column (elution of RIF activity at a NaCl concentration between 0.38 and 0.44 mol/L). Sequential purification by molecular sieve and anion exchange chromatography yielded pure protein, as documented by SDS-PAGE (Fig 4) with RIF activity. Aminoacid analysis of the 12.5-Kd and 50-Kd protein band gave identical results. This strongly supports the suggestion of a monomer of 12.5-Kd with a tendency to aggregation or polymerization. Rechromatography of the 100-Kd peak on a LKB TDK 4000 Blue Column (HPLC) revealed activity in the 50-Kd and 25-Kd fraction. Chromatofocusing showed activity in fractions at pH 7.8 to 8.1.
Biochemical and Biologic Properties
Incubation of sheep or human erythrocytes with RIF did not show a reliable effect on E rosetting, whereas incubation of T lymphocytes reproducibly showed significant inhibition. For that reason activity of a given material (supernatant or column fractions) was tested by incubation of T lymphocytes.
The optimal incubation period for the demonstration of the RIF effect was 60 minutes at 37"C, with less inhibition at 30 minutes and no additional effect up to 180 minutes. Maximum achievable inhibition of healthy donor PBL rosetting was 60%, with a mean of 38% (in 184 healthy controls, P < .001). Using the T-ALL line L735, similar inhibition was demonstrable (mean 35%, n = 64, P < .001). In lymphocytes from patients with active Hodgkin's disease, the initially diminished E rosetting could not be further suppressed (Fig 5) . This impaired rosetting capacity of Hodgkin PBL could be restored by overnight incubation in at least 6% FCS. After FCS treatment of T cells from healthy donors as well as from Hodgkin's patients, less then 25% rosette inhibition by RIF incubation was observed, which we consider not to be significant. RIF also inhibited the rosetting of peripheral blood T cells and L735 with normal human erythrocytes.
E rosette inhibition by RIF has never been observed to reach 100%. A possible explanation might be an effect specific for some subpopulation(s). To address this problem we tested rosette inhibition on T4+ and T8+ lymphocyte populations from healthy donors. T4+ and T8+ subclasses were purified by overnight adhesion to plastic surfaces to remove monocytes and MACS25 to more than 95% as shown by FACS analysis. The E rosette inhibition was identical for both cell populations in these experiments (data not shown).
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Similar lo results of othet inves,igaton who have ,,,,rihed mtting-inhibitory factors from serum in patients with chronic renal failure,m hepatitis B," or early breast cancer.'? we found up to 60% inhibition of rosette formation.
The diminished rosetting capacity of PBL from Hodgkin's patients is not further decreased by exogenously added RIF. Whether this is due to the presence of "endogenous RIF" in the plasma of Hodgkin's patients remains to be proven. After CD2-ligand structurC on SRBCs. Howmer* staining with ble of diminishing the rwtte-forming capacity off lymph* For personal use only. on October 3, 2017. by guest www.bloodjournal.org From overnight incubation of HD-PBL in FCS, their impaired rosetting capacity returns to normal,I4 but treatment of these cells with RIF results in less than 25% E rosette inhibition, which is not significant. PBL from healthy donors, pretreated with FCS in the same way, also show only 25% rosette inhibition by RIF. The FCS effect cannot be overcome by simple washing. Human serum from healthy donors does not interfere with RIF activity, nor does overnight incubation with this serum restore the impaired rosetting of T cells from Hodgkin's patients.
RIF action appears to be dependent on cell metabolism, since activity is demonstrable after incubation of lymphocytes at 37OC but not at 4OC. RIF can be stored as a solution at -80°C or after lyophilization at -2OOC. Other conditions such as freezing at -20°C and storage at 4OC, 25OC, and 37oC lead to rapid total loss of activity. RIF is labile at unphysiologic acid and alkaline pH, resists heat treatment up to 56OC for 30 minutes, but is destroyed at 100OC. It is trypsin sensitive.
Partial purification by affinity, ion-exchange, and molecularsieve chromatography eluted activity in the lOO-Kd, 50-Kd, 25-Kd, and 12.5-Kd fraction, suggesting an oligomer of possibly identical subunits. This assumption is supported by identical aminoacid analysis for the 50-Kd and 12.5-Kd protein band and the disaggregation of the 100-Kd material into active fractions at 50-Kd and 12.5-Kd after rechromatography.
Activity of the factor follows a bell-shaped dose response relationship. Similar dose response curves have been reported for some growth f a~t o r s~~.~~ and l e c t i n~.~~.~~ Functional studies did not show any identity with other cytokines produced by the Hodgkin cell lines, such as colony-stimulating activity (CSA)," interleukin-1 (IL-1),22 Hodgkin-derived leucocyte factor (HDLF),Z3 or Hodgkinderived growth factor (HDGF).24 These other factors differ in mol wt and have been shown not to inhibit E rosetting. Other molecules that have been reported to suppress E rosetting of T lymphocytes such as oxygenated sterols,37 ferritin,38 and cer~loplasmin~~ are of higher prc.,taglandin E? of lower mol wt. RIF activity could not be extracted by low-density lipoprotein (LDL) separation methods but can bind to LDL (data not shown).
Definitive characterization of the described activity by glycopeptidase treatment and protein sequencing is in progress. The receptor and ligand responsible for E rosette formation have been identified and ~l o n e d .~.~ The human functional analog of the SRBC T11 target structure (LFA 3) has been determined.7,4' The CD2 receptor has recently been assigned the role of an alternative pathway of T-cell a c t i v a t i~n .~.~~ The binding sites of different MoAbs describe a functional division into two major regions of the CD2 molecule: T1 la and T110. Antibodies to the three epitopes of T l l a (Tll,lA, T l l , l A , T11,lB) interfere with binding of the natural ligand of the CD2 (LFA3/TllTS). The T110 region is not involved in binding of LFA3/TllTS. According to their role in activation of T cells via CD2, three epitopes of T1 10 (T11,2A, T11,2A, T11,2B) have been identified.
Blocking and activation tests are currently being conducted to identify the exact site of RIF interaction with the CD2 receptor. Up to now, blocking studies with MoAbs have been performed on the T 1 1,l A and T1 1 ,l B epitopes of the T l l a region of CD2 that mediates E rosetting through binding of the LFA3/TllTS antigen.26 Our preliminary results show no effect of RIF on T11,lA and T11,lB antibody binding either at 37°C or at 4OC. This may be due to the much higher affinity of antibodies for their target structures as compared to that of the receptor for its ligand, as has been shown for the LFAl/ICAMl interaction. Dustin and Springer43 showed an increased adhesiveness of LFAl to ICAM1 by second-antibody crosslinking of T3Ti (TCR). This was transient and temperature dependent and not associated with a change in cell surface expression as measured by immunostaining.
As upregulation or downregulation of receptor expression or functional modulation by a third activation site cannot be excluded, further experiments on expression and regulation by cell metabolism have to be performed.
Discovery of the physiologic relevance of the CD2 receptor fuels speculation concerning RIF. The receptor is postulated to be the region of influence of RIF and is at the same time a means of T-cell activation, be it alone or in combination with other receptors. If RIF could be demonstrated to interfere with the activation of T cells, this could help to explain one step in the pathogenesis of the functional T-cell defect in Hodgkin's patients. 
